Table:
begin	end	state
1	31	cytoplasmic
32	53	transmembrane
54	58	non-cytoplasmic
59	84	transmembrane
85	117	cytoplasmic
118	143	transmembrane
144	150	non-cytoplasmic
151	168	transmembrane
169	179	cytoplasmic
180	201	transmembrane
202	224	non-cytoplasmic
225	243	transmembrane
244	254	cytoplasmic
255	278	transmembrane
279	300	non-cytoplasmic
301	330	transmembrane
331	350	cytoplasmic
351	372	transmembrane
373	376	non-cytoplasmic
377	399	transmembrane
400	419	cytoplasmic
420	435	transmembrane
436	440	non-cytoplasmic
441	459	transmembrane
460	470	cytoplasmic
471	491	transmembrane
492	497	non-cytoplasmic

Input:
>Pf6N2E2_1517
MATHLQGTEPVIPTVTPHPLAGSLRKVEPRRLSLSLLIALVVGSMIGSGIFSLPQNMAAS
AGAGAILIGWLITGVGMLSLALVYQTLSNRQPELDNGVFAYARALGGEFLGFNSAWGYWI
SAWIGNVSYLVILFAALSYFFPVFGEGNNKAAIVGASVVLWALHWMILRGMRTAAKANAL
TTIAKVVPLLLFIGLVIAAFSKDTFMVDFWGTPALGSTLDQVKSTMLVTVWVFIGIEGAN
VFSARAAERADVGRATVIGFILTLMLLIAVSLLSLGILRQPELAALKNPSMAGVLEAVAG
PWGAVLISIGLIVSVGGALLAWTLLAAESVFTPAKEKVMPRLLATENQHGAPANALWITN
GCIQLFLLLTLYSSASYLALISLATSMILLPYLFSGLYALKMTWQGQTYAGHRGLQLRDM
AIAVVATGYCVWLLYAAGPRYMLLSALLYAPGSLIYLSAQRARTGRALTGFGWGLLLVIW
AAAIFAGWMLWSGQLTL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server